Results 141 to 150 of about 429,194 (230)

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1831-1841, September 2026.
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem, Angel Liu, Sargis Manukyan, Mustafa Subhi, Elaina Luskin, Bryan Quah, Sreekanth Madhusoodhanan Nair, Arzu C. Has Silemek, Gabriela Zabala, Yujie Cui, Laura Locke, Paula Barreras, Marwa Kaisey, Vinicius Calsavara, Daniel S. Reich, Nancy L. Sicotte, Pascal Sati, Omar Al‐Louzi   +17 more
wiley   +1 more source

Distinguishing Molecular and Histologic Glioblastomas Using Multiparametric MRI-Based Habitat Analysis. [PDF]

Korean J Radiol
Choi M, Choi Y, Lee J, Jeong SY, Kim M, Hwang I, Park JE, Park YW, Choi SH, Choi KS.   +9 more
europepmc   +1 more source

Quantification of Phosphorylated Tau Protein in Alzheimer's Disease Patients’ Fluids With Electrolyte‐Gated Organic Transistor Biosensors

Advanced Healthcare Materials, Volume 15, Issue 36, 25 September 2026.
Dementia syndrome affects millions of people in the world, and Alzheimer's disease (AD) is the most common cause. We report the detection of the specific biomarker for AD, p‐tau‐181, from physiological to pathological concentrations in cerebrospinal fluid using an electrolyte‐gated organic transistor biosensor.
Marcello Berto, Pamela A. Manco Urbina, Alessandro Paradisi, Matteo Sensi, Najara Iacovino, Chiara Carbone, Roberta Bedin, Marcello Pinti, Fabio Biscarini, Giovanna Zamboni, Carlo A. Bortolotti   +10 more
wiley   +1 more source

Multiparametric MRI and artificial intelligence for non-invasive HER2 assessment in breast cancer: a comprehensive review. [PDF]

Front Med (Lausanne)
Zhang Y, Cheng S, Yang Q, He Y, Zhang X, Ji G.   +5 more
europepmc   +1 more source

Comparing diagnostic prostate cancer biomarkers using a framework of clinically meaningful criteria

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objectives To synthesize existing biomarker literature and generate a framework for meaningful comparison between five commonly used diagnostic prostate cancer biomarkers—prostate health index (phi), 4KScore, SelectMDx, ExoDx and MyProstate Score (MPS)—to provide evidence of greatest practical value to providers managing men with an elevated ...
Shu Wang, Behnam Nabavizadeh, Ashwin Ramaswamy, Meena Davuluri, Tenny R. Zhang, Michael Tzeng, Nathan Feiertag, Jim C. Hu   +7 more
wiley   +1 more source

Machine Learning with Multiparametric MRI and Clinical Biomarkers for Noninvasive Renal Interstitial Fibrosis Staging. [PDF]

Bioengineering (Basel)
Wang K, Zhao T, Su T, Jiang Y, Jiang L, Qiu J, Quan S, Liu J, Wang R.   +8 more
europepmc   +1 more source

The use of biparametric magnetic resonance imaging in active surveillance of prostate cancer

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objectives This study aims to evaluate the performance of biparametric magnetic resonance imaging (bpMRI) compared to multiparametric MRI (mpMRI) for active surveillance (AS) in prostate cancer (PCa), focusing on lesion detection, PI‐RADS classification changes and grade reclassification (GR) rates.
Carlos A. Rivera López, Michelle I. Higgins, Yuezhou Jing, Mark N. Alshak, Joseph G. Cheaib, Mufaddal Mamawala, Patricia Landis, Mohammad E. Allaf, Katarzyna J. Macura, Christian P. Pavlovich   +9 more
wiley   +1 more source

Calibrated and explainable multiparametric MRI radiomics for differentiating tumor positive disease from treatment-related changes in glioblastoma. [PDF]

Front Oncol
Christodoulou RC, Vamvouras G, Esmeraldo MA, Papageorgiou PS, Vassiliou E, Solomou EE, Papageorgiou SG, Georgiou MF.   +7 more
europepmc   +1 more source

Natural Compounds Targeting Oncogenic Signaling Networks in Glioblastoma: Molecular Mechanisms, Translational Advances, and Clinical Perspectives

Brain and Behavior, Volume 16, Issue 9, September 2026.
Glioblastoma (GBM) is a highly aggressive brain tumor with a poor prognosis, driven by abnormal signaling pathways that promote growth and resistance to treatment. Conventional therapies are inadequate, highlighting the need for novel multitargeted approaches.
Mehrukh Zehravi, Md Abul Hassan, Md. Al Amin, Sherouk Hussein Sweilam, Jeetendra Kumar Gupta, Ramenani Hari Babu, Pericharla Venkata Narasimha Raju, Krishna Vamsi Kandimalla, Phanindra Erukulla, Patibandla Jahnavi, Rajeshwar Vodeti, Abdul Ajeed Mohathasim Billah, Safia Obaidur Rab, Sharuk L. Khan   +13 more
wiley   +1 more source

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study. [PDF]

J Nucl Med
Farolfi A, Sgro CMP, Brusa I, Dall'Olio D, Romei F, Presutti M, Droghetti M, Di Giorgio A, Mei R, Corcioni B, Gaudiano C, Mosconi C, Schiavina R, Castellucci P, Fanti S, Bianchi L.   +15 more
europepmc   +1 more source